Group One Trading, L.P. Novo Cure LTD Transaction History

Group One Trading, L.P.

$3.01 Billion
Q2 2024

A detailed history of Group One Trading, L.P. transactions in Novo Cure LTD stock. As of the latest transaction made, Group One Trading, L.P. holds 12,476 shares of NVCR stock, worth $219,702. This represents 0.01% of its overall portfolio holdings.

Number of Shares

12,476

Previous 66,195 81.15%

Holding current value

$219,702

Previous $1.03 Million 79.4%

% of portfolio

0.01%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$11.83 - $24.05 $635,495 - $1.29 Million	-53,719 Reduced 81.15%	12,476 $213,000
Q1 2024 May 10, 2024	SELL	$12.42 - $17.29 $1.61 Million - $2.23 Million	-129,245 Reduced 66.13%	66,195 $1.03 Million
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $2.18 Million - $3.08 Million	195,440 New	195,440 $2.92 Million
Q2 2023 Aug 09, 2023	BUY	$40.29 - $82.51 $870,062 - $1.78 Million	21,595 Added 91.55%	45,184 $1.88 Million
Q1 2023 May 12, 2023	BUY	$56.44 - $118.81 $1.33 Million - $2.8 Million	23,589 New	23,589 $1.42 Million
Q1 2022 May 12, 2022	SELL	$60.15 - $84.52 $2.97 Million - $4.17 Million	-49,390 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$75.08 - $121.99 $2.46 Million - $4 Million	32,827 Added 198.19%	49,390 $3.71 Million
Q3 2021 Nov 12, 2021	BUY	$116.17 - $194.55 $1.92 Million - $3.22 Million	16,563 New	16,563 $1.92 Million
Q3 2020 Nov 12, 2020	SELL	$58.05 - $111.31 $912,197 - $1.75 Million	-15,714 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$57.2 - $74.41 $898,840 - $1.17 Million	15,714 New	15,714 $932,000
Q1 2020 May 13, 2020	SELL	$57.05 - $95.75 $160,995 - $270,206	-2,822 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$68.3 - $93.8 $127,311 - $174,843	1,864 Added 194.57%	2,822 $238,000
Q3 2019 Nov 12, 2019	BUY	$61.86 - $97.8 $59,261 - $93,692	958 New	958 $72,000
Q4 2018 Feb 06, 2019	SELL	$28.72 - $52.63 $431,345 - $790,449	-15,019 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$32.0 - $52.4 $188,640 - $308,898	5,895 Added 64.61%	15,019 $787,000
Q2 2018 Aug 14, 2018	BUY	$19.85 - $32.0 $168,784 - $272,096	8,503 Added 1369.24%	9,124 $286,000
Q1 2018 May 11, 2018	SELL	$19.3 - $23.65 $164,532 - $201,616	-8,525 Reduced 93.21%	621 $14,000
Q4 2017 Feb 09, 2018	BUY	$16.3 - $21.9 $149,079 - $200,297	9,146	9,146 $185,000

Others Institutions Holding NVCR

# of Institutions

272

Shares Held

77.2M

Call Options Held

751K

Put Options Held

293K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.85B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Novo Cure LTD Transaction History